SCHEMBL17630107

SCHEMBL17630107

N#Cc1ccc(-c2ccc(Br)cc2)c(CCc2ccncc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.47
CYP11B2 P19099 3/20 0.47
CYP19A1 P11511 2/20 0.47
FLT3 P36888 2/20 0.37
GCGR P47871 1/20 0.36
MAPK14 Q16539 1/20 0.36
MAOB P27338 2/20 0.35
KDM4E B2RXH2 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
SRPK2 P78362 1/20 0.34
SRPK1 Q96SB4 1/20 0.34
PDE5A O76074 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
PTGS1 P23219 1/20 0.34
PDE4A P27815 1/20 0.34
CYP2C19 P33261 1/20 0.34
BLM P54132 1/20 0.34
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17629912 0.85 CYP11B2 (0.47) CYP11B1CYP11B2CYP19A1FLT3KDM4E
SCHEMBL17629919 0.78 KDM1A (0.37) CYP11B1CYP11B2MAOBERBB2AHR
SCHEMBL17630089 0.75 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1PKN1PKN2
SCHEMBL17630001 0.75 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1PKN1PKN2
SCHEMBL17629922 0.74 KDM1A (0.41) ERBB2
SCHEMBL17630007 0.72 HRH2 (0.36) CYP11B1CYP11B2CYP19A1MAOBKDM4E
SCHEMBL17630189 0.71 ALDH1A1 (0.41) CYP11B2KDM4ETSHRPOLBAHR
SCHEMBL17630076 0.71 HRH2 (0.35) CYP11B1CYP11B2CYP19A1KDM4ELMNA
SCHEMBL8377267 0.70 CYP19A1 (0.43) CYP11B1CYP11B2CYP19A1MAOBTSHR
SCHEMBL29337092 0.70 MAOB (0.44) CYP19A1MAOBTSHRMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed